Productive engagement of the HLA Class I-bound peptide with the T-cell receptor (TCR) activates naïve CD8+ T-cells, transforming them into cytotoxic T cells, which mediate lysis of the neoepitope-expressing tumor cells [29]. Here, CD8A is linked to neoplasm.